Headline
The latest stories from AHA Today.
Draeger Medical, Inc. is recalling its Carina Ventilators due to the presence of contaminants in the device’s airpath, which exceed acceptable levels if used by pediatric patients for more than 30 days.
A new study by Business Group on Health reveals that, amid increases in the percentage of health care dollars spent on pharmacy, 92% of employers are concerned about high-cost drugs in the pipeline, with 91% reporting concern about pharmacy cost trends overall.
The Centers for Disease Control and Prevention Aug. 24 announced the launch of its Hospital Sepsis Program Core Elements initiative, a new program to provide hospitals with a blueprint to managing medical emergencies stemming from sepsis
Fisher-Titus' Stacy Daniel, director of clinical programs, and Katie Chieda, chief nursing officer, discuss their approach to recruiting international nurses to their community to ensure they remain a strong, independent health system for years to come.
AHA Board Chair John Haupert is among those named to the Congressional Budget Office’s 2023 Panel of Health Advisers, it was announced recently.
A new resource from the Cybersecurity and Infrastructure Security Agency, National Security Agency and the National Institute of Standards and Technology is helping hospitals and other critical infrastructure organizations get up to speed on the impacts of quantum capabilities in cybersecurity and…
The Delaware Hospital Association Aug. 18 named Brian Frazee as its new president and CEO. Prior to joining DHA, Frazee was with the Maryland Hospital Association, where he served as vice president of government affairs.
The Food and Drug Administration announced its approval of Pfizer’s Abrysvo (Respiratory Syncytial Virus Vaccine), the first vaccine approved for use in pregnant individuals to prevent lower respiratory tract disease and severe LRTD caused by respiratory syncytial virus in infants from birth…
A new report by the Centers for Disease Control and Prevention says 20% of women reported experiences of mistreatment during pregnancy and delivery care, with CDC saying the highest rates reported by Black, Hispanic and multiracial women.
AHA urged the House Energy and Commerce Committee to consider including in its draft legislation to address drug shortages legislative proposals that would support drug manufacturers and protect the supply chain for essential medications without limiting patient access to 340B drugs.